Pall Corporation announce strategic alliance with Applied Science Inc

The fully automated HemoFlow 400 from ASI combines a proprietary mixing action with a collection tracking system to maximise the use of whole blood donations at blood centres.
The fully automated HemoFlow 400 from ASI combines a proprietary mixing action with a collection tracking system to maximise the use of whole blood donations at blood centres.

The fully automated HemoFlow 400 from ASI combines a proprietary mixing action with a collection tracking system to maximise the use of whole blood donations at blood centres. The HemoFlow 400 audibly and visually guides users through the donation process and displays flow rates, elapsed time, current and target volume, total weight collected and any relevant messages in up to nine languages.

The HemoFlow 400 is highly flexible, can be used for both mobile and fixed site donations and requires no footprint in tight spaces due to its off-the-floor mounting. The unit is FDA 510k market cleared, CE-marked and comes with a 3 year limited warranty.

Jonathan Morgan, ASI president and CEO said: “Our strategic alliance with Pall leverages the credibility and distribution access that will assure customer satisfaction and deliver added-value to the blood banks that rely on Pall products to keep their operations running smoothly.”